Quest Diagnostics Incorporated, a leading provider in the diagnostic testing industry, is headquartered in the United States. Founded in 1967, the company has established itself as a pivotal player in laboratory services, offering a comprehensive range of diagnostic information services that include clinical laboratory testing, anatomic pathology, and genetic testing. With a strong operational presence across North America, Quest Diagnostics is renowned for its commitment to innovation and quality, providing unique solutions that enhance patient care. The company has achieved significant milestones, including advancements in molecular diagnostics and a robust network of patient service centres. Recognised for its market leadership, Quest Diagnostics continues to set the standard in the healthcare sector, delivering reliable and accurate testing services that empower healthcare providers and patients alike.
How does Quest Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Quest Diagnostics's score of 27 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Quest Diagnostics reported significant carbon emissions, totalling approximately 107,228,000 kg CO2e for Scope 1 and 91,613,000 kg CO2e for Scope 2. The Scope 1 emissions included mobile combustion (about 72,268,000 kg CO2e), process emissions (approximately 5,506,000 kg CO2e), and fugitive emissions (around 4,293,000 kg CO2e). The company also disclosed Scope 3 emissions, which amounted to about 820,410,000 kg CO2e, primarily from purchased goods and services (approximately 512,089,000 kg CO2e) and employee commuting (around 145,072,000 kg CO2e). Despite these figures, Quest Diagnostics has not set specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further action in addressing their carbon footprint. The company continues to engage in climate-related reporting, indicating a commitment to transparency in their environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
2015 | 2016 | 2021 | 2022 | |
---|---|---|---|---|
Scope 1 | 83,929,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | 41,299,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quest Diagnostics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.